AbbVie (ABBV) Other Working Capital Changes (2012 - 2026)

AbbVie (ABBV) has 15 years of Other Working Capital Changes data on file, last reported at $150.0 million in Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at $150.0 million, down 76.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $349.0 million (down 36.66% YoY), and the FY2025 annual result was $827.0 million, up 329.09% from the prior year.
• Other Working Capital Changes declined to $150.0 million in Q1 2026 per ABBV's latest filing, from $658.0 million in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $658.0 million in Q4 2025 and troughed at -$452.0 million in Q2 2023.
• A 5-year average of $62.8 million and a median of $74.0 million in 2022 frame the typical range for Other Working Capital Changes.
• On a YoY basis, Other Working Capital Changes climbed as much as 558.0% in 2025 and fell as far as 1384.0% in 2025.
• A 5-year view of Other Working Capital Changes shows it stood at $204.0 million in 2022, then jumped by 185.29% to $582.0 million in 2023, then slumped by 82.82% to $100.0 million in 2024, then surged by 558.0% to $658.0 million in 2025, then sank by 77.2% to $150.0 million in 2026.
• Business Quant data shows ABBV's Other Working Capital Changes at $150.0 million in Q1 2026, $658.0 million in Q4 2025, and -$88.0 million in Q3 2025.